American Century Companies
KYTX icon

American Century Companies’s Kyverna Therapeutics KYTX Stock Holding History

American Century Companies’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$459K Buy
53,235
+6,868
+15% +$57.2K ﹤0.01% 2534
2025
Q4 		$436K Buy
46,367
+14,162
+44% +$105K ﹤0.01% 2547
2025
Q3 		$193K Buy
+32,205
New +$129K ﹤0.01% 2700

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

American Century Companies's KYTX Position: Q1 2026 in Review

American Century Companies increased its Kyverna Therapeutics (KYTX) stake by 15% in Q1 2026, buying an estimated $57.2K and bringing the position to 53,235 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

American Century Companies first reported a position in KYTX in Q3 2025 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • American Century Companies held 53,235 shares of Kyverna Therapeutics worth $459K as of Q1 2026.
  • American Century Companies bought 6,868 Kyverna Therapeutics shares in Q1 2026, an estimated $57.2K.
  • Kyverna Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2534 holding.
  • American Century Companies first reported a position in Kyverna Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.